Anticonvulsant mood stabilizers, antipsychotic drugs and the insulin resistance syndrome
Phase of Trial: Phase III
Latest Information Update: 16 Dec 2016
At a glance
- Drugs Antipsychotics; Aripiprazole; Mood stabilisers; Ziprasidone
- Indications Bipolar disorders; Schizoaffective disorder; Schizophrenia
- Focus Adverse reactions
- 23 Jan 2009 Status changed from suspended to completed, based on information from ClinicalTrials.gov.
- 12 Aug 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jun 2008 Pfizer reported as trial affiliate by ClinicalTrials.gov.